These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 20167603)

  • 41. Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation.
    Kim EJ; Sung JY; Lee HJ; Rhim H; Hasegawa M; Iwatsubo T; Min do S; Kim J; Paik SR; Chung KC
    J Biol Chem; 2006 Nov; 281(44):33250-7. PubMed ID: 16959772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphorylation and inactivation of glycogen synthase kinase 3β (GSK3β) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A).
    Song WJ; Song EA; Jung MS; Choi SH; Baik HH; Jin BK; Kim JH; Chung SH
    J Biol Chem; 2015 Jan; 290(4):2321-33. PubMed ID: 25477508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subcellular distribution of cyclin-dependent kinase-like 5 (CDKL5) is regulated through phosphorylation by dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A).
    Oi A; Katayama S; Hatano N; Sugiyama Y; Kameshita I; Sueyoshi N
    Biochem Biophys Res Commun; 2017 Jan; 482(2):239-245. PubMed ID: 27840050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome.
    McElyea SD; Starbuck JM; Tumbleson-Brink DM; Harrington E; Blazek JD; Ghoneima A; Kula K; Roper RJ
    Hum Mol Genet; 2016 Nov; 25(22):4856-4869. PubMed ID: 28172997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
    Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
    J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phosphorylation of amphiphysin I by minibrain kinase/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome.
    Murakami N; Xie W; Lu RC; Chen-Hwang MC; Wieraszko A; Hwang YW
    J Biol Chem; 2006 Aug; 281(33):23712-24. PubMed ID: 16733250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DYRK3 activation, engagement of protein kinase A/cAMP response element-binding protein, and modulation of progenitor cell survival.
    Li K; Zhao S; Karur V; Wojchowski DM
    J Biol Chem; 2002 Dec; 277(49):47052-60. PubMed ID: 12356771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The NAD(+)-dependent protein deacetylase activity of SIRT1 is regulated by its oligomeric status.
    Guo X; Kesimer M; Tolun G; Zheng X; Xu Q; Lu J; Sheehan JK; Griffith JD; Li X
    Sci Rep; 2012; 2():640. PubMed ID: 22962634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CSAG2 is a cancer-specific activator of SIRT1.
    Yang X; Potts PR
    EMBO Rep; 2020 Sep; 21(9):e50912. PubMed ID: 32761762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A.
    Nguyen TL; Duchon A; Manousopoulou A; Loaëc N; Villiers B; Pani G; Karatas M; Mechling AE; Harsan LA; Limanton E; Bazureau JP; Carreaux F; Garbis SD; Meijer L; Herault Y
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30115750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual-specificity tyrosine-phosphorylation regulated kinase 1A Gene Transcription is regulated by Myocyte Enhancer Factor 2D.
    Wang P; Wang L; Chen L; Sun X
    Sci Rep; 2017 Aug; 7(1):7240. PubMed ID: 28775333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetic properties of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways.
    Adayev T; Chen-Hwang MC; Murakami N; Wegiel J; Hwang YW
    Biochemistry; 2006 Oct; 45(39):12011-9. PubMed ID: 17002300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DYRK1A regulates the recruitment of 53BP1 to the sites of DNA damage in part through interaction with RNF169.
    Menon VR; Ananthapadmanabhan V; Swanson S; Saini S; Sesay F; Yakovlev V; Florens L; DeCaprio JA; Washburn MP; Dozmorov M; Litovchick L
    Cell Cycle; 2019 Mar; 18(5):531-551. PubMed ID: 30773093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A.
    Fernandez-Martinez J; Vela EM; Tora-Ponsioen M; Ocaña OH; Nieto MA; Galceran J
    J Cell Sci; 2009 May; 122(Pt 10):1574-83. PubMed ID: 19383720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphorylation of Munc18-1 by Dyrk1A regulates its interaction with Syntaxin 1 and X11α.
    Park JH; Jung MS; Kim YS; Song WJ; Chung SH
    J Neurochem; 2012 Sep; 122(5):1081-91. PubMed ID: 22765017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome.
    Liu F; Liang Z; Wegiel J; Hwang YW; Iqbal K; Grundke-Iqbal I; Ramakrishna N; Gong CX
    FASEB J; 2008 Sep; 22(9):3224-33. PubMed ID: 18509201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome.
    Wegiel J; Dowjat K; Kaczmarski W; Kuchna I; Nowicki K; Frackowiak J; Mazur Kolecka B; Wegiel J; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Gong CX; Liu F; Adayev T; Chen-Hwang MC; Hwang YW
    Acta Neuropathol; 2008 Oct; 116(4):391-407. PubMed ID: 18696092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased dosage of DYRK1A and brain volumetric alterations in a YAC model of partial trisomy 21.
    Sebrié C; Chabert C; Ledru A; Guedj F; Po C; Smith DJ; Rubin E; Rivals I; Beloeil JC; Gillet B; Delabar JM
    Anat Rec (Hoboken); 2008 Mar; 291(3):254-62. PubMed ID: 18231969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DYRK1A: a potential drug target for multiple Down syndrome neuropathologies.
    Becker W; Soppa U; Tejedor FJ
    CNS Neurol Disord Drug Targets; 2014 Feb; 13(1):26-33. PubMed ID: 24152332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome.
    Wegiel J; Kaczmarski W; Barua M; Kuchna I; Nowicki K; Wang KC; Wegiel J; Yang SM; Frackowiak J; Mazur-Kolecka B; Silverman WP; Reisberg B; Monteiro I; de Leon M; Wisniewski T; Dalton A; Lai F; Hwang YW; Adayev T; Liu F; Iqbal K; Iqbal IG; Gong CX
    J Neuropathol Exp Neurol; 2011 Jan; 70(1):36-50. PubMed ID: 21157379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.